News Regulated Transparency/Denominator Regulated Information / Transparency Statement EN NL April 27, 2018
General News Regulated Disclosure in accordance with Belgian Law of 2 May 2007 EN NL January 30, 2018
News Regulated Transparency/Denominator NOVARTIS PHARMA AG HOLDING 5.69% OF THROMBOGENICS EQUITY CAPITAL EN NL January 26, 2018
General News Regulated ThromboGenics – Patient Enrolment in Phase II CIRCLE Study Evaluating THR-409 (ocriplasmin) for Non-Proliferative Diabetic Retinopathy Discontinued due to Slow Recruitment Rate EN December 8, 2017
